Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

935
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
935

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cu<sub>4</sub>SnS<sub>4</sub>-Functionalized Absorbent Pads-Derived Carbon as a Bifunctional Electrode for Supercapacitors and Hydrogen Evolution Reaction.

Nanomaterials (Basel, Switzerland)·2026
Same author

Chitosan-Curcumin Bioactive Platforms: Mechanistic Synergy, Antimicrobial Performance, and Design Principles for Next-Generation Wound Therapies.

Polymers·2026
Same author

Advanced Grafting Biomaterials and Technologies in Chronic Wound Care: Mechanisms, Clinical Outcomes, and Therapeutic Integration.

Journal of functional biomaterials·2026
Same author

Chitosan nanocrystals as next-generation antimicrobials: Mechanistic insights, antibiotic synergy, and biomedical potential.

Biotechnology advances·2026
Same author

Nanoengineered γ MnO<sub>2</sub> Accelerates the Degradation of Antibiotic-Resistant Biofilms.

Life (Basel, Switzerland)·2026
Same author

Biofilm Control with Rare-Earth Oxides: A Mechanistic Framework for Next-Generation Antibiofilm Materials.

Nanomaterials (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 8, 2026

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
08:58

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood

Published on: April 16, 2016

11.1K

Emerging Human Fetuin A Assays for Biomedical Diagnostics.

Sandeep Kumar Vashist1, E Marion Schneider2, A G Venkatesh3

  • 1Immunodiagnostic Systems, Rue Ernest Solvay 101, 4000 Liege, Belgium.

Trends in Biotechnology
|January 18, 2017
PubMed
Summary
This summary is machine-generated.

Human fetuin A (HFA) assays are advancing rapidly, with new technologies enabling easier monitoring of disease biomarkers. This review analyzes progress and future directions in HFA diagnostics.

More Related Videos

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.3K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
08:58

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood

Published on: April 16, 2016

11.1K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.3K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.6K

Area of Science:

  • Biochemistry
  • Clinical Diagnostics
  • Biomarker Discovery

Background:

  • Human fetuin A (HFA) is a significant biomarker implicated in various diseases, including osteoporosis and impaired calcium metabolism.
  • Calciprotein particle formation is a key pathological process involving HFA.
  • Advances in in vitro diagnostics have revolutionized biomarker detection.

Purpose of the Study:

  • To critically analyze the recent advancements in human fetuin A (HFA) assay development.
  • To discuss the challenges and future prospects of HFA detection methods.
  • To highlight the trend towards integrated diagnostic platforms for biomarker monitoring.

Main Methods:

  • Review of recent literature on HFA immunoassay technologies.
  • Analysis of high-sensitivity immunoassay procedures, surface plasmon resonance, and rapid assay chemistries.
  • Evaluation of emerging technologies like lab-on-chip platforms and smartphone detection.

Main Results:

  • Significant progress has been made in developing sensitive and rapid HFA assays.
  • Emerging technologies offer potential for point-of-care diagnostics and patient self-monitoring.
  • Lab-on-chip platforms with smartphone integration represent the future trend in HFA diagnostics.

Conclusions:

  • HFA assays have evolved significantly, moving towards integrated and user-friendly platforms.
  • Continued innovation in assay technology is crucial for effective disease management and monitoring.
  • Future HFA diagnostics will likely involve accessible, real-time biomarker monitoring for healthcare providers and patients.